Bridin Murnion

Back to

I am a senior staff specialist in clinical pharmacology and toxicology at St. Vincent's Hospital. I am a conjoint Associate Professor at St. Vincent's Clinical School. My research areas span neuropsychopharmacology, drugs of abuse, opioid use in pain and dependence and medicines use in priority populations. My vision is to optimise the quality use of medicines in priority populations.

Phone

02 8382 1111

E-mail

b.murnion@unsw.edu.au

Location

St Vincent's Clinical School, UNSW Medicine, UNSW Sydney Department of Clinical Pharmacology & Toxicology Therapeutics Centre, Level 2 Xavier Building St Vincent's Hospital Sydney Darlinghurst NSW 2010

Book Chapters | 2016

Islam MM; Nielsen S; McRae IS; Haber PS; Demirkol A; Murnion B; Wilson H; Conigrave KM, 2016, 'Chapter 28 Prescribing and Dispensing of Benzodiazepines Implications for Dependence and Misuse', in Neuropathology of Drug Addictions and Substance Misuse, Elsevier, pp. 283 - 292,

Book Chapters | 2016

Islam MM; Nielsen S; McRae IS; Haber PS; Demirkol A; Murnion B; Wilson H; Conigrave KM, 2016, 'Prescribing and Dispensing of Benzodiazepines: Implications for Dependence and Misuse', in Neuropathology of Drug Addictions and Substance Misuse, pp. 283 - 292,

Book Chapters | 2015

Murnion B, 2015, 'Pain Education Curriculum in Medical Schools', in Textbook of Addiction Treatment: International Perspectives, Springer Milan, pp. 2473 - 2479,
Journal articles | 2024

Langford AV; Bero L; Lin CWC; Blyth FM; Doctor JN; Holliday S; Jeon YH; Moullin JC; Murnion B; Nielsen S; Penm J; Reeve E; Reid S; Wale J; Osman R; Gnjidic D; Schneider CR, 2024, 'Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care', Journal of Clinical Epidemiology, 165,

Journal articles | 2024

McNamara KA; Black K; Bond O; Murnion B; Gordon A; Ludlow J; Nassar N, 2024, 'Planning postpartum contraception for women with substance use disorders: Utilisation of the birth admission', Australian and New Zealand Journal of Obstetrics and Gynaecology,

Journal articles | 2024

McNamara KA; Murnion B; Fotheringham P; Terplan M; Lintzeris N; Oei JL; Bond DM; Nassar N; Black KI, 2024, 'Interconnections between unintended pregnancy, alcohol and other drug use, and pregnancy, birth, infant, childhood and socioeconomic outcomes: a scoping review', BMJ Sexual and Reproductive Health, 50, pp. 285 - 293,

Journal articles | 2024

McNamara KA; Murnion B; Lintzeris N; Chase V; Black E; Malcolm A; Harvey Dodds L; Nassar N; Black KI, 2024, 'Integration of a facilitated access pathway for contraception into alcohol and other drug treatment services: A cohort study comparing metropolitan and regional settings', Drug and Alcohol Review,

Journal articles | 2024

McNeilage AG; Sim A; Nielsen S; Murnion B; Ashton-James CE, 2024, 'Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review', International Journal of Drug Policy, 133,

Journal articles | 2024

White CJ; Bailey S; Murnion B; Plit M; Darley D, 2024, 'Acute Tacrolimus Toxicity Due to Paxlovid Successfully Managed with Phenytoin After Lung Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S480 - S481,

Journal articles | 2023

Athavale A; Murnion B, 2023, 'Gabapentinoids: a therapeutic review', Australian Prescriber, 46, pp. 80 - 85,

Journal articles | 2023

Chin PKL; Charles K; Murnion B; McGuire TM; Hilmer SN; Martin J; Reith D; Joyce D; Lucas C; Holford N; Day R; Schneider J; Doogue M; Han CH; Herd S; Harrison C; O'Mara D, 2023, 'Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand', British Journal of Clinical Pharmacology, 89, pp. 3105 - 3115,

Journal articles | 2023

Jamshidi N; Athavale A; Tremonti C; McDonald C; Banukumar S; Vazquez S; Luquin N; Santiago M; Murnion B, 2023, 'Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testing', British Journal of Clinical Pharmacology, 89, pp. 1938 - 1947,

Journal articles | 2023

Jones CMP; Day RO; Koes BW; Latimer J; Maher CG; McLachlan AJ; Billot L; Shan S; Lin CWC; McLachlan H; Webb M; Hamilton M; Ahedi H; Barber A; Mak W; Mathieson S; Petrova V; Bompoint S; Murnion B; Buckley N; Demirkol A; Wrigley P; Needs C; Brooks L; Cantori S; Preisz P; Aitken J; Allan S; Burke M; Cameron G; Cepeda FJV; Davis C; Dullur J; Emmanuel J; Errey C; Fieuw-Makaroff S; Gaudry A; Genua L; Longhurst I; McCroary K; Merhi D; Nguyen T; Obayd ZR; Penm M; Pobbathi S; Poh WS; Schnitzler P; Shahnaz S; Tan V; Tang D; Tan B; Thu WK; Triantopolous T; Venkatesan R; Wong WCF; Yang SC, 2023, 'Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial', The Lancet, 402, pp. 304 - 312,

Journal articles | 2023

Langford AV; Lin CCW; Bero L; Blyth FM; Doctor J; Holliday S; Jeon YH; Moullin J; Murnion B; Nielsen S; Osman R; Penm J; Reeve E; Reid S; Wale J; Schneider CR; Gnjidic D, 2023, 'Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations', Medical Journal of Australia, 219, pp. 80 - 89,

Journal articles | 2023

Lobbe C; Bahnisch J; Lin C; Demirkol A; Murnion B, 2023, 'How do patients and staff in an opioid agonist treatment service view smoking cessation medications and e-cigarettes?', Drug and Alcohol Review, 42, pp. 1092 - 1103,

Journal articles | 2023

McNeilage AG; Nielsen S; Murnion B; Ashton-James C, 2023, 'Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review protocol', BMJ Open, 13,

Journal articles | 2023

Murnion B; Carland JE; Jefferies M; Au M; Tracy M, 2023, '‘It’s a fragile open door’—enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder', Journal of Public Health (United Kingdom), 45, pp. e729 - e736,

Journal articles | 2022

Dowla R; Sinmaz H; Mavros Y; Murnion B; Cayanan E; Rooney K, 2022, 'The Effectiveness of Exercise as an Adjunct Intervention to Improve Quality of Life and Mood in Substance Use Disorder: A Systematic Review', Substance Use and Misuse, 57, pp. 911 - 928,

Journal articles | 2022

Dowla RJ; Stubley C; Murnion B; Cayanan E; Mavros Y; Hardy S; Rooney K, 2022, 'Fitness in recovery: impact of exercise in people with substance use disorder in residential treatment', International Journal of Clinical Trials, 9, pp. 279 - 279,

Journal articles | 2022

Foran A; Tremonti C; Balgobind V; Sakr H; Murnion B, 2022, 'Transferring patients from high-dose methadone to buprenorphine: A retrospective case series', Journal of Opioid Management, 18, pp. 557 - 566,

Journal articles | 2022

Graham M; Martin JH; Lucas CJ; Murnion B; Schneider J, 2022, 'Cannabidiol drug interaction considerations for prescribers and pharmacists', Expert Review of Clinical Pharmacology, 15, pp. 1383 - 1397,

Journal articles | 2022

Murnion B; Schaffer A; Cairns R; Brett J, 2022, 'Gabapentinoids: repeating mistakes of the past?', Addiction, 117, pp. 2969 - 2971,

Journal articles | 2022

Murnion BP; Demirkol A, 2022, 'Opioid use disorder in anaesthesia and intensive care: Prevention, diagnosis and management', Anaesthesia and Intensive Care, 50, pp. 95 - 107,

Journal articles | 2022

Murnion BP; Roberts DM, 2022, 'Responding to the rising number of suicides using barbiturates', Medical Journal of Australia, 216, pp. 187 - 188,

Journal articles | 2022

Nielsen S; Picco L; Murnion B; Winters B; Matheson J; Graham M; Campbell G; Parvaresh L; Khor KE; Betz-Stablein B; Farrell M; Lintzeris N; Le Foll B, 2022, 'Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies', Neuropsychopharmacology, 47, pp. 1315 - 1330,

Journal articles | 2022

Stojanova J; Carland JE; Murnion B; Seah V; Siderov J; Lemaitre F, 2022, 'Therapeutic drug monitoring in oncology - What’s out there: A bibliometric evaluation on the topic', Frontiers in Oncology, 12,

Journal articles | 2022

Tay E; Lo WKW; Murnion B, 2022, 'Current Insights on the Impact of Gamma-Hydroxybutyrate (GHB) Abuse', SUBSTANCE ABUSE AND REHABILITATION, 13, pp. 13 - 23,

Journal articles | 2021

Dowla R; Murnion B; Hung C; Currell K; Kendig M; Freeston J; Rooney K, 2021, 'Exercise Capacity and Acute Effect of Exercise on Affect in a Substance Use Disorder Population', Journal of Clinical Exercise Physiology, 10, pp. 142 - 149,

Journal articles | 2021

Jamshidi N; Athavale A; Murnion B, 2021, 'Buprenorphine not detected on urine drug screening in supervised treatment', Journal of Opioid Management, 17, pp. 69 - 76,

Journal articles | 2021

Jamshidi N; Clark D; Murnion B, 2021, 'Recurrent Takotsubo Cardiomyopathy Associated with Opioid Withdrawal During Buprenorphine Induction', Cardiovascular Toxicology, 21, pp. 349 - 353,

Journal articles | 2021

Manandhar P; Murnion BP; Grimsey NL; Connor M; Santiago M, 2021, 'Do gabapentin or pregabalin directly modulate the µ receptor?', PeerJ, 9,

Journal articles | 2021

McCartney D; Isik AD; Rooney K; Arnold JC; Bartlett DJ; Murnion B; Richards E; Arkell TR; Lintzeris N; McGregor IS, 2021, 'The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial', Journal of Sleep Research, 30,

Journal articles | 2021

Murnion B; Dhaliwal A; Alsop J, 2021, 'Patient characteristics predicting attendance for elective in-patient treatment of substance use disorder', Australasian Psychiatry, 29, pp. 659 - 662,

Journal articles | 2020

Cohen M; Murnion B, 2020, 'Does "dependence" on opioids constitute a distinct clinical state?', Pain, 161, pp. 1682 - 1683,

Journal articles | 2020

Murnion BP; Rivas C; Demirkol A; Hayes V; Lintzeris N; Nielsen S, 2020, 'Acute Experimental Pain Responses in Methadone-and Buprenorphine/Naloxone-Maintained Patients Administered Additional Opioid or Gabapentin: A Double-Blind Crossover Pilot Study', Pain Medicine (United States), 21, pp. 1188 - 1198,

Journal articles | 2019

Athavale A; Murnion B, 2019, 'Unique approach to continuing medical education in clinical pharmacology across Australia and New Zealand', Internal Medicine Journal, 49, pp. 1488 - 1495,

Journal articles | 2019

Cappetta M; Murnion BP, 2019, 'Inpatient management of gamma-hydroxybutyrate withdrawal', Australasian Psychiatry, 27, pp. 284 - 287,

Journal articles | 2019

Murnion B; Conigrave KM, 2019, 'Pregabalin misuse: the next wave of prescription medication problems', Medical Journal of Australia, 210, pp. 72 - 73,

Journal articles | 2019

Nielsen S; Murnion B; Campbell G; Young H; Hall W, 2019, 'Cannabinoids for the treatment of spasticity', Developmental Medicine and Child Neurology, 61, pp. 631 - 638,

Journal articles | 2018

Cooper S; Campbell G; Larance B; Murnion B; Nielsen S, 2018, 'Perceived stigma and social support in treatment for pharmaceutical opioid dependence', Drug and Alcohol Review, 37, pp. 262 - 272,

Journal articles | 2018

Dowla R; Murnion B; Roberts K; Freeston J; Rooney K, 2018, 'Physical activity assessment in clinical studies of substance use disorder', , 1735, pp. 273 - 284,

Journal articles | 2018

Murnion B, 2018, 'A man using codeine long term for foot pain: Alternative pain management and opioid cessation', Medicine Today, 19, pp. 29 - 30

Journal articles | 2018

Murnion B, 2018, 'Neuropathic pain - definition and drug therapy', AUSTRALIAN PRESCRIBER, 41, pp. 179 - 179,

Journal articles | 2018

Murnion BP, 2018, 'Neuropathic pain: Current definition and review of drug treatment', Australian Prescriber, 41, pp. 60 - 63,

Journal articles | 2018

Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A, 2018, 'Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.', Res Social Adm Pharm,

Journal articles | 2018

Nielsen S; Lintzeris N; Murnion B; Degenhardt L; Bruno R; Haber P; Johnson J; Hardy M; Ling S; Saddler C; Dunlop A; Demirkol A; Silsbury C; Phung N; Houseman J; Larance B, 2018, 'Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence', Drug and Alcohol Review, 37, pp. 887 - 896,

Journal articles | 2018

Stockings E; Campbell G; Hall WD; Nielsen S; Zagic D; Rahman R; Murnion B; Farrell M; Weier M; Degenhardt L, 2018, 'Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies', Pain, 159, pp. 1932 - 1954,

Journal articles | 2017

Allsop DJ; Rooney K; Arnold JC; Bhardwaj AK; Bruno R; Bartlett DJ; Montebello M; Arkell T; Richards E; Gugusheff J; Rooke S; Kerley W; Murnion B; Haber P; McGregor IS; Lintzeris N, 2017, 'Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol', Mental Health and Physical Activity, 13, pp. 57 - 67,

Journal articles | 2017

Nielsen S; Sabioni P; Trigo JM; Ware MA; Betz-Stablein BD; Murnion B; Lintzeris N; Khor KE; Farrell M; Smith A; Le Foll B, 2017, 'Opioid-sparing effect of cannabinoids: A systematic review and meta-analysis', Neuropsychopharmacology, 42, pp. 1752 - 1765,

Journal articles | 2016

McNamara K, 2016, 'Benzodiazepines', AUSTRALIAN PRESCRIBER, 39, pp. 33 - 33,

Journal articles | 2016

Nielsen S; Bruno R; Murnion B; Dunlop A; Degenhardt L; Demirkol A; Muhleisen P; Lintzeris N, 2016, 'Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia', Drug and Alcohol Review, 35, pp. 70 - 75,

Journal articles | 2015

Brett J; Murnion B, 2015, 'Management of benzodiazepine misuse and dependence', Australian Prescriber, 38, pp. 152 - 155,

Journal articles | 2015

Brett J; Murnion B, 2015, 'Pregabalin to treat ciguatera fish poisoning', Clinical Toxicology, 53, pp. 588,

Journal articles | 2015

Murnion B, 2015, 'Medicinal cannabis', Australian Prescriber, 38, pp. 212 - 215,

Journal articles | 2015

Nielsen S; Bruno R; Murnion B; Dunlop A; Degenhardt L; Demirkol A; Muhleisen P; Lintzeris N, 2015, 'OPIOID PHARMACOTHERAPY DOSE REQUIREMENTS FOR OXYCODONE AND MORPHINE DEPENDENCE', DRUG AND ALCOHOL REVIEW, 34, pp. 47 - 48,

Journal articles | 2015

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber PS; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2015, 'LONGER TERM OUTCOMES FOR PHARMACEUTICAL OPIOID DEPENDENCE: 12 MONTH FINDINGS FROM AN IN-TREATMENT COHORT', DRUG AND ALCOHOL REVIEW, 34, pp. 48 - 48,

Journal articles | 2015

Nielsen S; Murnion B; Dunlop A; Degenhardt L; Demirkol A; Muhleisen P; Lintzeris N, 2015, 'Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series', Drug and Alcohol Review, 34, pp. 304 - 311,

Journal articles | 2014

Nielsen S; Larance B; Lintzeris N; Black E; Bruno R; Murnion B; Dunlop A; Degenhardt L, 2014, 'Is pain associated with illicit opioid use or aberrant opioid-related behaviors in opioid substitution treatment patients', Drug and Alcohol Dependence, 140, pp. e162 - e162,

Journal articles | 2013

Nielsen S; Larance BK; Lintzeris N; Black E; Bruno R; Murnion B; Dunlop A; Degenhardt LJ, 2013, 'Correlates of pain in an in-treatment sample of opioid-dependent people', Drug and Alcohol Review, 32, pp. 489 - 494,

Journal articles | 2012

Murnion B, 2012, 'Management of opioid substitution therapy during medical intervention', Internal Medicine Journal, 42, pp. 242 - 246,

Journal articles | 2011

Bowron P; Murnion B, 2011, 'Combination analgesics in adults', Australian Prescriber, 34, pp. 4 - 5,

Journal articles | 2011

Haber PS; Murnion BP, 2011, 'Training in addiction medicine in australia', Substance Abuse, 32, pp. 115 - 119,

Journal articles | 2011

Mitchell SJ; Hilmer SN; Murnion BP; Matthews S, 2011, 'Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: Impact of ageing and frailty', Journal of Clinical Pharmacy and Therapeutics, 36, pp. 327 - 335,

Journal articles | 2011

Murnion B, 2011, 'Reply: Combination analgesics in adults', Australian Prescriber, 34, pp. 4 - 5

Journal articles | 2010

Lintzeris N; Bruno R; Dunlop A; Murnion B, 2010, 'SYMPOSIUM - HOW SHOULD AUSTRALIAN DRUG TREATMENT SERVICES BE RESPONDING TO PHARMACEUTICAL DRUG USE?', DRUG AND ALCOHOL REVIEW, 29, pp. 41 - 41,

Journal articles | 2010

Murnion BP; Gnjidic D; Hilmer SN, 2010, 'Prescription and administration of opioids to hospital in-patients, and barriers to effective use', Pain Medicine, 11, pp. 58 - 66,

Journal articles | 2010

Murnion BP, 2010, 'Combination analgesics in adults', Australian Prescriber, 33, pp. 113 - 115,

Journal articles | 2009

Haber PS; Demirkol A; Lange K; Murnion B, 2009, 'Management of injecting drug users admitted to hospital', The Lancet, 374, pp. 1284 - 1293,

Journal articles | 2009

Hilmer SN; Perera V; Mitchell S; Murnion BP; Dent J; Bajorek B; Matthews S; Rolfson DB, 2009, 'The assessment of frailty in older people in acute care', Australasian Journal on Ageing, 28, pp. 182 - 188,

Journal articles | 2009

Leong M; Murnion B; Haber PS, 2009, 'Examination of opioid prescribing in Australia from 1992 to 2007: ORIGINAL ARTICLE', Internal Medicine Journal, 39, pp. 676 - 681,

Journal articles | 2009

Mitchell SJ; Murnion BP; Matthews ST; Hilmer SN, 2009, 'Compliance with paracetamol prescribing policies at a Sydney Hospital', Journal of Pharmacy Practice and Research, 39, pp. 122 - 127,

Journal articles | 2008

Gnjidic D; Murnion BP; Hilmer SN, 2008, 'Age and opioid analgesia in an acute hospital population', Age and Ageing, 37, pp. 699 - 702,

Journal articles | 2008

Murnion B, 2008, 'Reply [2]', EMA - Emergency Medicine Australasia, 20, pp. 91,

Journal articles | 2007

Granot R; Day RO; Cohen ML; Murnion B; Garrick R, 2007, '639: Targeted pharmacotherapy of evoked phenomena in neuropathic pain', Journal of Clinical Neuroscience, 14, pp. 1031 - 1031,

Journal articles | 2007

Granot R; Day RO; Cohen ML; Murnion B; Garrick R, 2007, 'Targeted pharmacotherapy of evoked phenomena in neuropathic pain: A review of the current evidence', Pain Medicine, 8, pp. 48 - 64,

Journal articles | 2007

Murnion BP; Granot R; Day RO, 2007, 'Utility of urine drug screening: A clinical audit', EMA - Emergency Medicine Australasia, 19, pp. 246 - 252,

Journal articles | 2005

Byrne A; Graham G; Hallinan R; Murnion B; Hulse GK; Arnold-Reed DE; Wodak A; Graham R; Hulse GK, 2005, 'Naltrexone implants as treatment for heroin dependence: Part I (multiple letters)', Addiction Biology, 10, pp. 201,

Journal articles | 2003

Fucito LM; Gomes BS; Murnion B; Haber PS, 2003, 'General practitioners' diagnostic skills and referral practices in managing patients with drug and alcohol-related health problems: Implications for medical training and education programmes', Drug and Alcohol Review, 22, pp. 417 - 424,

Journal articles | 2002

Murnion BP, 2002, 'Brain Imaging in substance abuse: Research, clinical and forensic applications', DRUG AND ALCOHOL REVIEW, 21, pp. 95 - 96,

Journal articles | 1993

Johnston AR; Murnion B; McQueen DS; Dutia MB, 1993, 'Excitation and inhibition of rat medial vestibular nucleus neurones by 5-hydroxytryptamine', Experimental Brain Research, 93, pp. 293 - 298,
Preprints | 2023

A KM; Murnion B; Fotheringham P; Terplan M; Lintzeris N; Oei JL; Bond D; Nassar N; Black K, 2023, Interconnections between unintended pregnancy, alcohol and other drug use, and pregnancy, birth, infant, childhood, and socio-economic outcomes: a scoping review, ,

Conference Papers | 2021

Chase V; Murnion B; Mcnamara K; Carniato G; Masters K, 2021, 'REDUCING UNINTENDED PREGNANCY: DRUG AND ALCOHOL SERVICES PREGNANCY INTENTION AND CONTRACEPTION PROJECT', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S55 - S55,

Conference Papers | 2021

Jefferies M; Graham R; Murnion B; Tracy M; Douglas M; George J, 2021, 'THE REGULATION OF TECHNOLOGY DISCOURAGES NOVELTY AND HOLDS DRUG HEALTH SERVICE BACK DURING COVID-19', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S84 - S85,

Conference Papers | 2021

Jefferies M; Phung N; Graham R; Lam T; Shahidi M; Murnion B; Tracy M; George J; Douglas M; Mohammed E, 2021, 'GENETIC RISK FACTORS IN PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S85 - S85,

Conference Papers | 2021

Jefferies M; Phung N; Lam T; Graham R; Shahidi M; Murnion B; Tracy M; George J; Douglas M; Mohammed E, 2021, 'A NOVEL GENOTYPE IN PATIENTS WITH ALCOHOL USE DISORDER', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S86 - S86,

Conference Abstracts | 2018

Stockings E; Campbell G; Hall WD; Nielsen S; Zagic D; Rahman R; Murnion B; Farrell M; Weier M; Degenhardt L, 2018, 'CANNABINOIDS FOR THE TREATMENT OF CHRONIC NON-CANCER PAIN: AN OVERVIEW OF THE EVIDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S69 - S69,

Conference Papers | 2017

Bhardwaj AK; Allsop DJ; Rooney K; Arnold J; Bruno R; Montebello M; Gugusheff J; Kerley W; Murnion BP; Haber PS; McGregor IS; Lintzeris N, 2017, 'RANDOMISED CONTROLLED TRIAL OF DAILY AEROBIC EXERCISE FOR INPATIENT CANNABIS WITHDRAWAL', in DRUG AND ALCOHOL REVIEW, WILEY, pp. 21 - 21,

Conference Abstracts | 2017

Nielsen S; Larance B; Lintzeris N; Holliday S; Dunlop AJ; Haber PS; Murnion BP; Silsbury C; Johnson J; Demirkol A; Ling S; Sadler C; Phung N; Bruno R; Hardy M; Brown AL; Houseman J; Degenhardt L, 2017, 'TREATING OVER THE COUNTER CODEINE DEPENDENCE: TWO YEAR OUTCOMES FROM A COHORT OF PHARMACEUTICAL OPIOID DEPENDENT PEOPLE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 13 - 14,

Conference Abstracts | 2017

Nielsen S; Murnion BP; Rivas C; Demirkol A; Lintzeris N, 2017, 'LACK OF ANALGESIC EFFICACY OF OPIOIDS AND GABAPENTIN ON ACUTE EXPERIMENTAL PAIN RESPONSES IN METHADONE MAINTAINED PATIENTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 55 - 55,

Conference Presentations | 2014

Nielsen S; Bruno R; Murnion B; Dunlop A; Degenhardt L; Demirkol A; Muhleisen P; Lintzeris N, 2014, 'TREATING CODEINE DEPENDENCE WITH BUPRENORPHINE: HOW MUCH IS ENOUGH?'

Conference Presentations | 2014

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber P; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2014, 'SEEKING TREATMENT FOR PHARMACEUTICAL OPIOID DEPENDENCE: BASELINE CHARACTERISTICS FROM AN IN-TREATMENT COHORT'

Conference Presentations | 2013

Nielsen S; Muhleisen P; Murnion B; Sadler C; Ling S; Smith C; Demirkol A; Dunlop AJ; Degenhardt L; Lintzeris N, 2013, 'PHARMACEUTICAL OPIOID TREATMENT PRESENTATIONS PRESCRIBED METHADONE OR BUPRENORPHINE IN THREE NEW SOUTH WALES LOCAL HEALTH DISTRICT DRUG TREATMENT SERVICES',

Conference Papers | 2012

Demirkol A; Haber P; Murnion B, 2012, 'SUBSTANCE USE IN OLDER PATIENTS', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 3 - 3,

Conference Presentations | 2011

Black E; Larance B; Mattick R; Lintzeris N; Degenhardt L; Bruno R; Nielsen S; Murnion B; Cohen M; Ali R; Dunlop A; Holland R, 2011, 'MINIMISING THE UNINTENDED CONSEQUENCES OF OPIOID TREATMENT: DEVELOPMENT OF A DRUG BEHAVIOUR SCALE FOR USE IN AUSTRALIA',

��������Ƶ

Follow

Bridin Murnion

��Ƶ